Ryan Larson

Q: What is Ryan Larson email address?

Email Ryan Larson at ryanalarson@gmail.com. This email is the most updated Ryan Larson email found in 2026.

Q: How to contact Ryan Larson?

To contact Ryan Larson send an email to ryanalarson@gmail.com. If you want to call Ryan Larson try calling on +16174442231.

Senior Director at Odyssey Therapeutics | Watertown, Massachusetts, United States

About Ryan Larson

Ryan Larson currently serves as Senior Director at Odyssey Therapeutics, where he leverages his extensive expertise in clinical development to drive innovative projects in the biopharmaceutical sector. With a strong background in the pharmaceutical industry, Ryan is adept at navigating the complexities of bringing novel, first-in-class molecules from the laboratory to clinical trials. His role involves overseeing cross-functional teams to ensure that all aspects of drug development adhere to Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and other regulatory standards.

At Odyssey Therapeutics, Ryan is instrumental in spearheading key projects that focus on advancing cutting-edge therapies aimed at addressing unmet medical needs. His leadership style fosters a collaborative environment, encouraging team members to contribute their insights and expertise. This approach not only enhances team cohesion but also drives innovation in the development process. Ryan's proficiency in regulatory submissions and validation processes ensures that projects remain compliant and on track for successful outcomes.

In addition to his project leadership, Ryan is committed to mentoring the next generation of professionals in the biotechnology field. He actively shares his knowledge of Standard Operating Procedures (SOPs) and Good Laboratory Practice (GLP), emphasizing the importance of rigorous scientific methodology in clinical development. Through his work at Odyssey Therapeutics, Ryan Larson exemplifies the qualities of an effective leader, combining a positive, focused approach with a deep understanding of the biopharmaceutical landscape to deliver impactful therapeutic solutions.

Ryan Larson Work